Top Markets
#1 Siacoin Siacoin +36.50%
#2 Official Trump Official Trump +27.66%
#3 Wrapped STX (Velar) Wrapped STX (Velar) +20.27%
#4 Melania Meme Melania Meme +19.29%
#5 EXOD EXOD +18.93%
#6 MowCat MowCat +18.35%
#7 Pump.fun Pump.fun +16.85%
#8 Unit Pump Unit Pump +16.85%
#9 The Bitcoin Bull The Bitcoin Bull +16.34%
#10 Siren Siren +15.88%
Coin of the day
Siacoin Siacoin
Settings
Language
ENGLISH
Currency
USD
Theme
Taiwan Bio Therapeutics Co., Ltd Taiwan Bio Therapeutics Co., Ltd

Taiwan Bio Therapeutics Co., Ltd

6892
Rank in Stocks #23260
Taiwan Bio Therapeutics Co., Ltd. is an enterprise specializing in regenerative... Taiwan Bio Therapeutics Co., Ltd. is an enterprise specializing in regenerative medicine, primarily dedicated to the development of novel cellular therapeutics. These advanced treatments are crafted to address a range of medical conditions, including degenerative disorders, cardiovascular ailments, complications stemming from diabetes, and autoimmune diseases. The company was established in 2014 and its operations are headquartered in Taipei City, Taiwan.
Share Price
$0.81087521
Last synced: 2026-08-21
Market Cap
$76.23M
Change (1 day)
0.39%
Change (1 year)
-26.90%
Country
TW
Trade Taiwan Bio Therapeutics Co., Ltd (6892)

Category

Healthcare
Revenue for Taiwan Bio Therapeutics Co., Ltd (6892)
Revenue in Aug 2026 TTM: 0
According to Taiwan Bio Therapeutics Co., Ltd latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Taiwan Bio Therapeutics Co., Ltd from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH